Related Experiment Video
Updated: Jun 13, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Comprehensive Analysis of Genomic and Phenomic Data Reveals Context-Dependent Function of A20 (TNFAIP3) in Renal Cell
Nour Abu Jayab1,2, Burcu Yener1,3, Reem Sami Alhamidi1
1Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
Background:
A20, encoded by tumor necrosis factor alpha-induced protein 3 (TNFAIP3), is a key negative regulator of NF-κB signaling with context-dependent functions in cancer. Its role in renal cell carcinoma (RCC), particularly clear-cell RCC (ccRCC), remains incompletely defined.
Methods:
Public GEO transcriptomic data from 23 controls and 32 ccRCC samples were analyzed using gene set enrichment analysis (GSEA). A20-overexpressing HEK293 and 786-O cells were assessed by functional assays and transcriptomic profiling. Eight ccRCC FFPE samples were profiled to compare A20-associated transcriptional patterns with cell-line data. Targeted DNA sequencing was performed in 11 ccRCC and 8 papillary RCC samples, and whole-exome sequencing was conducted in A20-overexpressing 786-O cells. Key genes were further evaluated using Kaplan-Meier survival analysis in 530 ccRCC patients and TCGA-KIRC data comprising 533 primary tumors and 72 normal samples.
Results:
GEO analysis showed significant TNFAIP3/A20 upregulation in ccRCC (p = 3.96 × 10-5) and enrichment of NF-κB-related gene sets (p = 0.01). A20 overexpression produced distinct phenotypes in HEK293 and 786-O cells. In HEK293 cells, A20 increased BIK and ARHGAP6 expression and was associated with increased apoptosis and reduced wound closure. In 786-O cells, A20 suppressed ARHGAP6 and APAF1 and was associated with increased proliferation, enhanced wound closure, and reduced apoptosis relative to EV controls. A20-high ccRCC samples showed enrichment of NF-κB, TGF-β, DNA repair, mTOR/metabolic, hypoxia, and proteasome-related pathways. Genomic analyses identified alterations in NF-κB-related genes, including CARD10 and IRAK1. Conclusions: A20/TNFAIP3 may exert cell-context-dependent effects in RCC and is associated with tumor-relevant transcriptional and genomic alterations requiring further validation.
Insights
A20 (TNFAIP3) shows increased expression in clear-cell renal cell carcinoma (ccRCC) and influences cell behavior differently depending on the cell type. This suggests A20 has context-dependent roles in ccRCC progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- A20 (TNFAIP3) is a negative regulator of NF-κB signaling with known context-dependent roles in cancer.
- The specific function of A20 in renal cell carcinoma (RCC), especially clear-cell RCC (ccRCC), is not fully understood.
Purpose of the Study:
- To investigate the role and impact of A20/TNFAIP3 in ccRCC.
- To analyze the transcriptional and genomic alterations associated with A20 expression in ccRCC.
Main Methods:
- Analysis of public transcriptomic data (GEO) from ccRCC and control samples.
- Functional assays and transcriptomic profiling of A20-overexpressing cell lines (HEK293, 786-O).
- DNA sequencing and survival analysis using patient data (TCGA-KIRC).
Main Results:
- Significant upregulation of TNFAIP3/A20 was observed in ccRCC, correlating with NF-κB pathway enrichment.
- A20 overexpression induced distinct cellular phenotypes, including altered apoptosis, proliferation, and migration in a cell-context-dependent manner.
- A20-high ccRCC samples showed enrichment of pathways involved in NF-κB signaling, TGF-β, DNA repair, metabolism, hypoxia, and proteasome function. Genomic analysis revealed alterations in NF-κB-related genes.
Conclusions:
- A20/TNFAIP3 exhibits context-dependent effects in RCC, influencing tumor-relevant pathways.
- A20 expression is associated with significant transcriptional and genomic alterations in ccRCC that warrant further investigation.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pharmacogenomics: Identification of New Drug Targets
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
